Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

β-Hemolytic Streptococcus anginosus subsp. anginosus causes streptolysin S-dependent cytotoxicity to human cell culture lines in vitro.

Tabata A, Yamada T, Ohtani H, Ohkura K, Tomoyasu T, Nagamune H.

J Oral Microbiol. 2019 May 8;11(1):1609839. doi: 10.1080/20002297.2019.1609839. eCollection 2019.

2.

Recognizability of heterologous co-chaperones with Streptococcus intermedius DnaK and Escherichia coli DnaK.

Tomoyasu T, Tsuruno K, Tanatsugu R, Miyazaki A, Kondo H, Tabata A, Whiley RA, Sonomoto K, Nagamune H.

Microbiol Immunol. 2018 Nov;62(11):681-693. doi: 10.1111/1348-0421.12651. Epub 2018 Nov 5.

PMID:
30239035
3.

Construction of Anti-HER2 Recombinants as Targeting Modules for a Drug-delivery System Against HER2-positive Cells.

Tang Q, Onitsuka M, Tabata A, Tomoyasu T, Nagamune H.

Anticancer Res. 2018 Jul;38(7):4319-4325. doi: 10.21873/anticanres.12731.

PMID:
29970568
4.

A novel plasmid, pSAA0430-08, from Streptococcus anginosus subsp. anginosus strain 0430-08.

Tabata A, Deutsch D, Otsuka S, Verratti K, Tomoyasu T, Nagamune H, Fischetti VA.

Plasmid. 2018 Jan;95:16-27. doi: 10.1016/j.plasmid.2018.01.002.

PMID:
29355570
5.

Rapid screening method for detecting highly pathogenic Streptococcus intermedius strains carrying a mutation in the lacR gene.

Tomoyasu T, Matoba M, Takao A, Tabata A, Whiley RA, Maeda N, Nagamune H.

FEMS Microbiol Lett. 2018 Feb 1;365(3). doi: 10.1093/femsle/fnx258.

PMID:
29228148
6.

Positive- and Negative-Control Pathways by Blood Components for Intermedilysin Production in Streptococcus intermedius.

Tomoyasu T, Yamasaki T, Chiba S, Kusaka S, Tabata A, Whiley RA, Nagamune H.

Infect Immun. 2017 Aug 18;85(9). pii: e00379-17. doi: 10.1128/IAI.00379-17. Print 2017 Sep.

7.

Development of a Sortase A-mediated Peptide-labeled Liposome Applicable to Drug-delivery Systems.

Tabata A, Ohkubo Y, Anyoji N, Hojo K, Tomoyasu T, Tatematsu Y, Ohkura K, Nagamune H.

Anticancer Res. 2015 Aug;35(8):4411-7.

PMID:
26168480
8.

Aortic regurgitation due to fibrous strand rupture in the fenestrated left coronary cusp of the tricuspid aortic valve.

Irisawa Y, Itatani K, Kitamura T, Hanayama N, Oka N, Tomoyasu T, Inoue N, Hayashi H, Inoue T, Miyaji K.

Int Heart J. 2014;55(6):550-1. Epub 2014 Oct 7.

9.
10.

[Outcomes of the surgical treatment of infectious endocarditis in a single institute for 13-years].

Irisawa Y, Kitamura T, Itatani K, Inoue T, Hayashi H, Sakaki K, Shibata M, Tomoyasu T, Oka N, Hanayama N, Torii S, Miyaji K.

Kyobu Geka. 2014 May;67(5):367-70. Japanese.

PMID:
24917280
11.

Identification and characterization of a novel secreted glycosidase with multiple glycosidase activities in Streptococcus intermedius.

Imaki H, Tomoyasu T, Yamamoto N, Taue C, Masuda S, Takao A, Maeda N, Tabata A, Whiley RA, Nagamune H.

J Bacteriol. 2014 Aug;196(15):2817-26. doi: 10.1128/JB.01727-14. Epub 2014 May 23.

12.

Aortic arch rerouting and OPCAB in a patient with situs inversus totalis.

Irisawa Y, Kitamura T, Taketani T, Hanayama N, Oka N, Tomoyasu T, Itatani K, Shibata M, Hayashi H, Inoue T, Miyaji K.

Int Heart J. 2014;55(3):278-9. Epub 2014 May 12.

13.

A streptolysin S homologue is essential for β-haemolytic Streptococcus constellatus subsp. constellatus cytotoxicity.

Tabata A, Sato Y, Maya K, Nakano K, Kikuchi K, Whiley RA, Ohkura K, Tomoyasu T, Nagamune H.

Microbiology. 2014 May;160(Pt 5):980-91. doi: 10.1099/mic.0.075580-0. Epub 2014 Mar 5.

PMID:
24600025
14.

Estrogen stimuli promote osteoblastic differentiation via the subtilisin-like proprotein convertase PACE4 in MC3T3-E1 cells.

Kim H, Tabata A, Tomoyasu T, Ueno T, Uchiyama S, Yuasa K, Tsuji A, Nagamune H.

J Bone Miner Metab. 2015 Jan;33(1):30-9. doi: 10.1007/s00774-014-0567-9. Epub 2014 Feb 21.

PMID:
24557631
15.

The diversity of receptor recognition in cholesterol-dependent cytolysins.

Tabata A, Ohkura K, Ohkubo Y, Tomoyasu T, Ohkuni H, Whiley RA, Nagamune H.

Microbiol Immunol. 2014 Mar;58(3):155-71. doi: 10.1111/1348-0421.12131.

16.

Five-week use of a monopivot centrifugal blood pump as a right ventricular assist device in severe dilated cardiomyopathy.

Inoue T, Kitamura T, Torii S, Hanayama N, Oka N, Itatani K, Tomoyasu T, Irisawa Y, Shibata M, Hayashi H, Ono M, Miyaji K.

J Artif Organs. 2014 Mar;17(1):95-8. doi: 10.1007/s10047-013-0740-2. Epub 2013 Nov 28.

PMID:
24288020
17.

LacR mutations are frequently observed in Streptococcus intermedius and are responsible for increased intermedilysin production and virulence.

Tomoyasu T, Imaki H, Masuda S, Okamoto A, Kim H, Waite RD, Whiley RA, Kikuchi K, Hiramatsu K, Tabata A, Nagamune H.

Infect Immun. 2013 Sep;81(9):3276-86. doi: 10.1128/IAI.00638-13. Epub 2013 Jun 24.

18.

Construction of an improved drug delivery system tool with enhanced versatility in cell-targeting.

Tabata A, Ohkubo Y, Tamura M, Tomoyasu T, Ohkura K, Nagamune H.

Anticancer Res. 2013 Jul;33(7):2905-10.

PMID:
23780978
19.

Neutrophil elastase inhibitor sivelestat attenuates perioperative inflammatory response in pediatric heart surgery with cardiopulmonary bypass.

Inoue N, Oka N, Kitamura T, Shibata K, Itatani K, Tomoyasu T, Miyaji K.

Int Heart J. 2013;54(3):149-53.

20.

Moderate prosthesis-patient mismatch may be negligible in elderly patients undergoing conventional aortic valve replacement for aortic stenosis.

Kitamura T, Torii S, Hanayama N, Oka N, Tomoyasu T, Irisawa Y, Shibata M, Hayashi H, Inoue T, Miyaji K.

Int Heart J. 2013;54(1):11-4.

21.

Novel twin streptolysin S-like peptides encoded in the sag operon homologue of beta-hemolytic Streptococcus anginosus.

Tabata A, Nakano K, Ohkura K, Tomoyasu T, Kikuchi K, Whiley RA, Nagamune H.

J Bacteriol. 2013 Mar;195(5):1090-9. doi: 10.1128/JB.01344-12. Epub 2013 Jan 4.

22.

Surgical strategy for severe aortic hypoplasia and aortic stenosis with ventricular septal defect and normal left ventricle.

Tomoyasu T, Oka N, Miyamoto T, Kitamura T, Itatani K, Inoue N, Ishii M, Miyaji K.

Pediatr Cardiol. 2013 Jun;34(5):1107-11. doi: 10.1007/s00246-012-0611-2. Epub 2012 Dec 19.

PMID:
23250649
23.

Small heat shock protein AgsA: an effective stabilizer of enzyme activities.

Tomoyasu T, Tabata A, Ishikawa Y, Whiley RA, Nagamune H.

J Biosci Bioeng. 2013 Jan;115(1):15-9. doi: 10.1016/j.jbiosc.2012.08.001. Epub 2012 Aug 26.

PMID:
22929984
24.

Investigation of a bacterial pore-forming chimera toxin for application as a novel drug-delivery system tool.

Tabata A, Ohkubo Y, Sakakura E, Tomoyasu T, Ohkura K, Nagamune H.

Anticancer Res. 2012 Jun;32(6):2323-9.

PMID:
22641669
25.

Role of Streptococcus intermedius DnaK chaperone system in stress tolerance and pathogenicity.

Tomoyasu T, Tabata A, Imaki H, Tsuruno K, Miyazaki A, Sonomoto K, Whiley RA, Nagamune H.

Cell Stress Chaperones. 2012 Jan;17(1):41-55. doi: 10.1007/s12192-011-0284-4. Epub 2011 Aug 6.

26.

Successful treatment of pediatric endocarditis and pericarditis due to MRSA with linezolid.

Miyamoto T, Tomoyasu T, Miyaji K.

Jpn J Antibiot. 2011 Apr;64(2):109-12.

PMID:
21717862
27.

Miniaturized biocompatible cardiopulmonary bypass for the Fontan procedure.

Itatani K, Miyaji K, Miyamoto T, Inoue N, Tomoyasu T, Kohira S, Sato H, Ohara K.

Surg Today. 2010 Nov;40(11):1040-5. doi: 10.1007/s00595-009-4178-3. Epub 2010 Nov 3.

PMID:
21046502
28.

Regional high-flow cerebral perfusion improves both cerebral and somatic tissue oxygenation in aortic arch repair.

Miyaji K, Miyamoto T, Kohira S, Itatani K, Tomoyasu T, Inoue N, Ohara K.

Ann Thorac Surg. 2010 Aug;90(2):593-9. doi: 10.1016/j.athoracsur.2010.03.113.

PMID:
20667356
29.

Investigation of the chaperone function of the small heat shock protein-AgsA.

Tomoyasu T, Tabata A, Nagamune H.

BMC Biochem. 2010 Jul 24;11:27. doi: 10.1186/1471-2091-11-27.

30.

Role of catabolite control protein A in the regulation of intermedilysin production by Streptococcus intermedius.

Tomoyasu T, Tabata A, Hiroshima R, Imaki H, Masuda S, Whiley RA, Aduse-Opoku J, Kikuchi K, Hiramatsu K, Nagamune H.

Infect Immun. 2010 Sep;78(9):4012-21. doi: 10.1128/IAI.00113-10. Epub 2010 Jul 12.

31.

The effectiveness of prestorage leukocyte-reduced red blood cell transfusion on perioperative inflammatory response with a miniaturized biocompatible bypass system.

Miyaji K, Miyamoto T, Kohira S, Itatani K, Tomoyasu T, Sato H, Ohara K.

J Thorac Cardiovasc Surg. 2010 Jun;139(6):1561-7. doi: 10.1016/j.jtcvs.2009.10.016. Epub 2009 Dec 28.

32.

Optimal conduit size of the extracardiac Fontan operation based on energy loss and flow stagnation.

Itatani K, Miyaji K, Tomoyasu T, Nakahata Y, Ohara K, Takamoto S, Ishii M.

Ann Thorac Surg. 2009 Aug;88(2):565-72; discussion 572-3. doi: 10.1016/j.athoracsur.2009.04.109.

PMID:
19632413
33.

The bilateral pulmonary artery banding for hypoplastic left heart syndrome with a diminutive ascending aorta.

Tomoyasu T, Miyaji K, Miyamoto T, Inoue N.

Interact Cardiovasc Thorac Surg. 2009 Apr;8(4):479-81. doi: 10.1510/icvts.2008.192534. Epub 2009 Jan 6.

PMID:
19126552
34.

Higher cerebral oxygen saturation may provide higher urinary output during continuous regional cerebral perfusion.

Miyamoto T, Miyaji K, Okamoto H, Kohira S, Tomoyasu T, Inoue N, Ohara K.

J Cardiothorac Surg. 2008 Oct 31;3:58. doi: 10.1186/1749-8090-3-58.

35.

Peptide derivation of poorly absorbable drug allows intestinal absorption via peptide transporter.

Kikuchi A, Tomoyasu T, Tanaka M, Kanamitsu K, Sasabe H, Maeda T, Odomi M, Tamai I.

J Pharm Sci. 2009 May;98(5):1775-87. doi: 10.1002/jps.21551.

PMID:
18781650
36.

Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli.

de Marco A, Deuerling E, Mogk A, Tomoyasu T, Bukau B.

BMC Biotechnol. 2007 Jun 12;7:32.

37.
38.

ClpXP controls the expression of LEE genes in enterohaemorrhagic Escherichia coli.

Tomoyasu T, Takaya A, Handa Y, Karata K, Yamamoto T.

FEMS Microbiol Lett. 2005 Dec 1;253(1):59-66. Epub 2005 Sep 23.

39.

Derepression of Salmonella pathogenicity island 1 genes within macrophages leads to rapid apoptosis via caspase-1- and caspase-3-dependent pathways.

Takaya A, Suzuki A, Kikuchi Y, Eguchi M, Isogai E, Tomoyasu T, Yamamoto T.

Cell Microbiol. 2005 Jan;7(1):79-90.

PMID:
15617525
41.

A new heat shock gene, AgsA, which encodes a small chaperone involved in suppressing protein aggregation in Salmonella enterica serovar typhimurium.

Tomoyasu T, Takaya A, Sasaki T, Nagase T, Kikuno R, Morioka M, Yamamoto T.

J Bacteriol. 2003 Nov;185(21):6331-9.

42.

Effects of disruption of heat shock genes on susceptibility of Escherichia coli to fluoroquinolones.

Yamaguchi Y, Tomoyasu T, Takaya A, Morioka M, Yamamoto T.

BMC Microbiol. 2003 Aug 12;3:16.

43.
44.

Lon, a stress-induced ATP-dependent protease, is critically important for systemic Salmonella enterica serovar typhimurium infection of mice.

Takaya A, Suzuki M, Matsui H, Tomoyasu T, Sashinami H, Nakane A, Yamamoto T.

Infect Immun. 2003 Feb;71(2):690-6.

45.

[Function of the Escherichia coli trigger factor].

Tomoyasu T.

Nihon Saikingaku Zasshi. 2002 Nov;57(4):597-605. Review. Japanese. No abstract available.

PMID:
12518387
46.

Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium.

Matsui H, Suzuki M, Isshiki Y, Kodama C, Eguchi M, Kikuchi Y, Motokawa K, Takaya A, Tomoyasu T, Yamamoto T.

Infect Immun. 2003 Jan;71(1):30-9.

47.

[Molecular mechanism of Hsp70 chaperones].

Mayer MP, Tomoyasu T, Bukau B.

Tanpakushitsu Kakusan Koso. 2002 Jul;47(9):1189-95. Review. Japanese. No abstract available.

PMID:
12166065
48.

The ClpXP ATP-dependent protease regulates flagellum synthesis in Salmonella enterica serovar typhimurium.

Tomoyasu T, Ohkishi T, Ukyo Y, Tokumitsu A, Takaya A, Suzuki M, Sekiya K, Matsui H, Kutsukake K, Yamamoto T.

J Bacteriol. 2002 Feb;184(3):645-53.

49.
50.

The C terminus of sigma(32) is not essential for degradation by FtsH.

Tomoyasu T, Arsène F, Ogura T, Bukau B.

J Bacteriol. 2001 Oct;183(20):5911-7.

Supplemental Content

Loading ...
Support Center